## Abstract ## Objective To provide a contemporary estimate of the prevalence and incidence of rheumatoid arthritis (RA) work disability and examine its permanence over time. ## Methods Data were collected semiannually from 5,384 subjects with rheumatologist‐diagnosed RA. We examined prevalence
Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis
✍ Scribed by Lacaille, Diane ;Sheps, Samuel ;Spinelli, John J. ;Chalmers, Andrew ;Esdaile, John M.
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 100 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objective
To define work‐related factors associated with increased risk of work disability (WD) in people with rheumatoid arthritis (RA).
Methods
Questionnaires were mailed to all RA patients who used a province‐wide arthritis treatment program between 1991 and 1998 (n = 1,824). The association between risk factors and WD (defined as no paid work due to RA for at least 6 months) was assessed using multiple logistic regression analysis, controlling for significant sociodemographic and disease‐related variables.
Results
Of the original 1,824 patients, 581 were eligible and responded to the questionnaire. Work survival analysis revealed a steady rate of WD starting early, with 7.5%, 18%, and 27% work disabled at 1, 5, and 10 years, respectively. Significant determinants in multiple logistic regression were physical function (Health Assessment Questionnaire), pain (visual analog scale), and 6 work‐related factors: self employment, workstation modification, work importance, family support toward employment, commuting difficulty, and comfort telling coworkers about RA.
Conclusion
Work disability occurs early in RA. Novel work‐related factors were identified, which are potentially modifiable, to help RA patients stay employed.
📜 SIMILAR VOLUMES
## Abstract ## Objective To compare the efficacy of therapy with a combination of disease‐modifying antirheumatic drugs (DMARDs) versus therapy with a single DMARD in the prevention of work disability in patients with early rheumatoid arthritis (RA). ## Methods In the Finnish Rheumatoid Arthriti